Evidence map›Paper›PMID 31775562›Full record

ArticleAutophagy2020

Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway.

Komal Qureshi-Baig, Diana Kuhn, Elodie Viry, Vitaly I Pozdeev, Martine Schmitz, Fabien Rodriguez, Pit Ullmann, Eric Koncina, Martin Nurmik, Sonia Frasquilho and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 2 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 2 syntheses or guidelines pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Understanding how hypoxia contributes to liver cancer stem cells maintenance.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Komal Qureshi-BaigMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Diana KuhnMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Elodie ViryMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Vitaly I PozdeevMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Martine SchmitzMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Fabien RodriguezMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Pit UllmannMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Eric KoncinaMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Martin NurmikMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Sonia FrasquilhoIntegrated Biobank of Luxembourg , Dudelange, Luxembourg.
Petr V NazarovProteome and Genome Research Unit, Luxembourg Institute of Health , Strassen, Luxembourg.
Nikolaus ZuegelDepartment of Surgery, Centre Hospitalier Emile Mayrisch , Esch-sur-Alzette, Luxembourg.
Marc BoulmontDepartment of Surgery, Centre Hospitalier Emile Mayrisch , Esch-sur-Alzette, Luxembourg.
Yervand KarapetyanIntegrated Biobank of Luxembourg , Dudelange, Luxembourg.
Laurent AntunesIntegrated Biobank of Luxembourg , Dudelange, Luxembourg.
Daniel ValDepartment of Anatomic and Molecular Pathology, Laboratoire National de Santé (LNS) , Dudelange, Luxembourg.
Michel MittelbronnDepartment of Anatomic and Molecular Pathology, Laboratoire National de Santé (LNS) , Dudelange, Luxembourg.
Bassam JanjiLaboratory of Experimental Cancer Research, Luxembourg Institute of Health , Strassen, Luxembourg.
Serge HaanMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.
Elisabeth LetellierMolecular Disease Mechanisms Group, Life Sciences Research Unit, University of Luxembourg , Esch-sur-Alzette, Luxembourg.ORCID 0000-0001-8242-9393
University of Luxembourg · LUCentral Bank of Luxembourg · LUCentre Hospitalier de Luxembourg · LULuxembourg Institute of Health · LULaboratoire National de Santé · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In solid tumors, cancer stem cells (CSCs) or tumor-initiating cells (TICs) are often found in hypoxic niches. Nevertheless, the influence of hypoxia on TICs is poorly understood. Using previously established, TIC-enrichedpatient-derived colorectal cancer (CRC) cultures, we show that hypoxia increases the self-renewal capacity of TICs while inducing proliferation arrest in their more differentiated counterpart cultures. Gene expression data revealed macroautophagy/autophagy as one of the major pathways induced by hypoxia in TICs. Interestingly, hypoxia-induced autophagy was found to induce phosphorylation of EZR (ezrin) at Thr567 residue, which could be reversed by knocking down ABBREVIATIONS: ATG: autophagy related; BECN1: beclin 1; BNIP3: BCL2 interacting protein 3; BNIP3L: BCL2 interacting protein 3 like; CQ: chloroquine; CSC: cancer stem cells; CRC: colorectal cancer; HIF1A/HIF-1α: hypoxia inducible factor 1 subunit alpha; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; PRKC/PKC: protein kinase C; SQSTM1/p62: sequestosome 1; TICs: tumor-initiating cells.

Indexed as

Disease ProgressionSignal TransductionAnimalsAutophagosomesAutophagyAutophagy-Related Protein 5CarcinogenesisCell Self RenewalColonColorectal NeoplasmsCytoskeletal ProteinsEzrinHumansHypoxiaMice, Inbred NODMice, SCIDAutophagy-Related Protein 5Cytoskeletal ProteinsEzrinProtein Kinase CAutophagycancer stem cellcolorectal cancerezrinhypoxiaprotein kinase Cself-renewal capacitytumor-initiating cell

Identifiers

PMID31775562
PMCPMC7469473
OpenAlexW2989893152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.